ALFRED W. SANDROCK, JR., M.D., PH.D.

Corporate Board Profile

Tech Score: 0/100

NEUROCRINE BIOSCIENCES INC

Filing Date	Source Excerpt
2017-04-21	Alfred W. Sandrock, Jr., M.D., Ph.D. has served on our Board of Directors since September 2015. He is a member of the Nominating/Corporate Governance Committee and the Science and Medical Technology Committee. Director Compensation Table shows total compensation of $470,658 for 2016.
2018-04-04	The continued service of Alfred W. Sandrock, Jr., M.D., Ph.D. on the Companys Board of Directors is based on his extensive experience and credentials in the biotechnology industry as an Executive Vice President of Biogen and his extensive experience in successfully leading development teams. In addition, Dr. Sandrocks medical expertise in neurology and his scientific background provide a unique contribution to the Board of Directors. The Companys Nominating/Corporate Governance Committee consists of directors Stephen A. Sherwin, M.D., George J. Morrow and Alfred W. Sandrock, Jr. M.D., Ph.D. The Companys Science and Medical Technology Committee consists of directors Gary A. Lyons, William H. Rastetter, Ph.D. and Alfred W. Sandrock, Jr. M.D., Ph.D. The following table sets forth the compensation paid by the Company for the fiscal year ended December 31, 2017 to the directors of the Company named below: Alfred W. Sandrock, Jr., M.D., Ph.D.: Fees Earned or Paid in Cash $64,000, Option Awards $442,950, Total $506,950.

Filing Date

Source Excerpt

2017-04-21

Alfred W. Sandrock, Jr., M.D., Ph.D. has served on our Board of Directors since September 2015. He is a member of the Nominating/Corporate Governance Committee and the Science and Medical Technology Committee. Director Compensation Table shows total compensation of $470,658 for 2016.

2018-04-04

The continued service of Alfred W. Sandrock, Jr., M.D., Ph.D. on the Companys Board of Directors is based on his extensive experience and credentials in the biotechnology industry as an Executive Vice President of Biogen and his extensive experience in successfully leading development teams. In addition, Dr. Sandrocks medical expertise in neurology and his scientific background provide a unique contribution to the Board of Directors. The Companys Nominating/Corporate Governance Committee consists of directors Stephen A. Sherwin, M.D., George J. Morrow and Alfred W. Sandrock, Jr. M.D., Ph.D. The Companys Science and Medical Technology Committee consists of directors Gary A. Lyons, William H. Rastetter, Ph.D. and Alfred W. Sandrock, Jr. M.D., Ph.D. The following table sets forth the compensation paid by the Company for the fiscal year ended December 31, 2017 to the directors of the Company named below: Alfred W. Sandrock, Jr., M.D., Ph.D.: Fees Earned or Paid in Cash $64,000, Option Awards $442,950, Total $506,950.

Data sourced from SEC filings. Last updated: 2026-02-03